• Return to Headlines

Enanta Pharmaceu Shares Up 38.5% Since SmarTrend's Buy Recommendation (ENTA)

By Amy Schwartz

SmarTrend identified an Uptrend for Enanta Pharmaceu (NYSE:ENTA) on March 27th, 2017 at $31.04. In approximately 5 months, Enanta Pharmaceu has returned 38.46% as of today's recent price of $42.97.

Over the past year, Enanta Pharmaceu has traded in a range of $20.79 to $45.14 and is now at $42.97, 107% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 1.4% while the 50-day MA has declined 0.7%.

Enanta Pharmaceuticals, Inc. manufactures pharmaceutical products. The Company develops, produces, and markets antibacterial drugs for hepatitis C virus, respiratory tract infections, intravenous, and oral treatments for hospitals and communities. Enanta Pharmaceuticals offers its products throughout the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Enanta Pharmaceu shares.

Log in and add Enanta Pharmaceu (ENTA) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights enanta pharmaceu

Ticker(s): ENTA